In conclusion, we have demonstrated that miR-221 is a potential oncomiR and functions as an oncogene to mediate tumor progression of TNBCs via targeting p27kip1 and inhibiting E-cadherin levels to mediate EMT transition. The gene discussed is CDH1; the disease is neoplasm.